249 related articles for article (PubMed ID: 38288834)
21. Anti-EGFR lipid micellar nanoparticles co-encapsulating quantum dots and paclitaxel for tumor-targeted theranosis.
Kang SJ; Jeong HY; Kim MW; Jeong IH; Choi MJ; You YM; Im CS; Song IH; Lee TS; Park YS
Nanoscale; 2018 Nov; 10(41):19338-19350. PubMed ID: 30307008
[TBL] [Abstract][Full Text] [Related]
22. Conjugation of quantum dots on carbon nanotubes for medical diagnosis and treatment.
Madani SY; Shabani F; Dwek MV; Seifalian AM
Int J Nanomedicine; 2013; 8():941-50. PubMed ID: 23487255
[TBL] [Abstract][Full Text] [Related]
23. Cancer antibody enhanced real time imaging cell probes--a novel theranostic tool using polymer linked carbon nanotubes and quantum dots.
Brakmane G; Madani SY; Seifalian A
Anticancer Agents Med Chem; 2013 Jun; 13(5):821-32. PubMed ID: 23537047
[TBL] [Abstract][Full Text] [Related]
24. Quantum Dots and their Potential Role in Cancer Theranostics.
Tripathi SK; Kaur G; Khurana RK; Kapoor S; Singh B
Crit Rev Ther Drug Carrier Syst; 2015; 32(6):461-502. PubMed ID: 26559550
[TBL] [Abstract][Full Text] [Related]
25. Theranostic Aspects: Treatment of Cancer by Nanotechnology.
Sarkar B; Paira P
Mini Rev Med Chem; 2018; 18(11):969-975. PubMed ID: 29189149
[TBL] [Abstract][Full Text] [Related]
26. Applications and Immunological Effects of Quantum Dots on Respiratory System.
Ren L; Wang L; Rehberg M; Stoeger T; Zhang J; Chen S
Front Immunol; 2021; 12():795232. PubMed ID: 35069577
[TBL] [Abstract][Full Text] [Related]
27. Quantum dot-based theranostics.
Ho YP; Leong KW
Nanoscale; 2010 Jan; 2(1):60-8. PubMed ID: 20648364
[TBL] [Abstract][Full Text] [Related]
28. Colloidal synthesis of tunably luminescent AgInS-based/ZnS core/shell quantum dots as biocompatible nano-probe for high-contrast fluorescence bioimaging.
Soheyli E; Ghaemi B; Sahraei R; Sabzevari Z; Kharrazi S; Amani A
Mater Sci Eng C Mater Biol Appl; 2020 Jun; 111():110807. PubMed ID: 32279757
[TBL] [Abstract][Full Text] [Related]
29. Quantum dot cytotoxicity and ways to reduce it.
Winnik FM; Maysinger D
Acc Chem Res; 2013 Mar; 46(3):672-80. PubMed ID: 22775328
[TBL] [Abstract][Full Text] [Related]
30. The targeting ability of fluorescent quantum dots to the folate receptor rich tumors.
Mangeolle T; Yakavets I; Lequeux N; Pons T; Bezdetnaya L; Marchal F
Photodiagnosis Photodyn Ther; 2019 Jun; 26():150-156. PubMed ID: 30885845
[TBL] [Abstract][Full Text] [Related]
31. Hybrid quantum dot-based theranostic nanomedicines for tumor-targeted drug delivery and cancer imaging.
Zayed DG; AbdElhamid AS; Freag MS; Elzoghby AO
Nanomedicine (Lond); 2019 Feb; 14(3):225-228. PubMed ID: 30652951
[No Abstract] [Full Text] [Related]
32. Luminescent quantum dots: Synthesis, optical properties, bioimaging and toxicity.
Sobhanan J; Rival JV; Anas A; Sidharth Shibu E; Takano Y; Biju V
Adv Drug Deliv Rev; 2023 Jun; 197():114830. PubMed ID: 37086917
[TBL] [Abstract][Full Text] [Related]
33. Oligonucleotide-based theranostic nanoparticles in cancer therapy.
Shahbazi R; Ozpolat B; Ulubayram K
Nanomedicine (Lond); 2016 May; 11(10):1287-308. PubMed ID: 27102380
[TBL] [Abstract][Full Text] [Related]
34. One-Step Aqueous Synthesis of Anionic and Cationic AgInS
Hashemkhani M; Loizidou M; MacRobert AJ; Yagci Acar H
Inorg Chem; 2022 Feb; 61(6):2846-2863. PubMed ID: 35104130
[TBL] [Abstract][Full Text] [Related]
35. QD-antibody conjugates via carbodiimide-mediated coupling: a detailed study of the variables involved and a possible new mechanism for the coupling reaction under basic aqueous conditions.
East DA; Mulvihill DP; Todd M; Bruce IJ
Langmuir; 2011 Nov; 27(22):13888-96. PubMed ID: 21970592
[TBL] [Abstract][Full Text] [Related]
36. Bypassing pro-survival and resistance mechanisms of autophagy in EGFR-positive lung cancer cells by targeted delivery of 5FU using theranostic Ag
Duman FD; Akkoc Y; Demirci G; Bavili N; Kiraz A; Gozuacik D; Acar HY
J Mater Chem B; 2019 Dec; 7(46):7363-7376. PubMed ID: 31696188
[TBL] [Abstract][Full Text] [Related]
37. Unravelling the Potential of Graphene Quantum Dots in Biomedicine and Neuroscience.
Perini G; Palmieri V; Ciasca G; De Spirito M; Papi M
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32466154
[TBL] [Abstract][Full Text] [Related]
38. Quantum dot as probe for disease diagnosis and monitoring.
Mukherjee A; Shim Y; Myong Song J
Biotechnol J; 2016 Jan; 11(1):31-42. PubMed ID: 26709963
[TBL] [Abstract][Full Text] [Related]
39. Preparation of biofunctionalized quantum dots using microfluidic chips for bioimaging.
Hu S; Zeng S; Zhang B; Yang C; Song P; Hang Danny TJ; Lin G; Wang Y; Anderson T; Coquet P; Liu L; Zhang X; Yong KT
Analyst; 2014 Sep; 139(18):4681-90. PubMed ID: 25054471
[TBL] [Abstract][Full Text] [Related]
40. Synthesis of multimodal polymersomes for targeted drug delivery and MR/fluorescence imaging in metastatic breast cancer model.
Zavvar T; Babaei M; Abnous K; Taghdisi SM; Nekooei S; Ramezani M; Alibolandi M
Int J Pharm; 2020 Mar; 578():119091. PubMed ID: 32007591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
